EP Patent

EP2280713A1 — Methods and kits for the treatment of inflammatory bowel disorder conditions

Assigned to Procter and Gamble Co · Expires 2011-02-09 · 15y expired

What this patent protects

The present invention comprises methods and kits that are useful for the treatment an inflammatory bowel disease. The methods comprise administering to a mammal in need of treatment a composition comprising an active agent in combination with a probiotic and/or optionally an anti…

USPTO Abstract

The present invention comprises methods and kits that are useful for the treatment an inflammatory bowel disease. The methods comprise administering to a mammal in need of treatment a composition comprising an active agent in combination with a probiotic and/or optionally an antibiotic.

Drugs covered by this patent

Patent Metadata

Patent number: EP2280713A1
Jurisdiction: EP
Classification: —
Expires: 2011-02-09
Drug substance claim: No
Drug product claim: No
Assignee: Procter and Gamble Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.